HSR Waiting Period Has Expired for the Acquisition of Substantially All of the Assets of Ivesco Holdings LLC

HSR Waiting Period Has Expired for the Acquisition of Substantially All of the 
Assets of Ivesco Holdings LLC 
BOISE, ID -- (Marketwired) -- 10/07/13 --   MWI Veterinary Supply,
Inc. ("MWI") (NASDAQ: MWIV) announced today that the waiting period
under the Hart-Scott-Rodino Antitrust Improvements Act (the "HSR
Act") for the proposed acquisition of substantially all of the assets
of IVESCO Holdings LLC ("IVESCO") expired on October 3, 2013. As
previously announced, MWI entered into a definitive agreement to
acquire substantially all of the assets of IVESCO for an enterprise
value of $67.5 million. The agreement is subject to certain customary
closing conditions. The expiration of the waiting period under the
HSR Act satisfies one of the closing conditions of the transaction. 
MWI is a leading distributor of animal health products across the
United States of America and United Kingdom. MWI sells both companion
animal and production animal products including pharmaceuticals,
vaccines, parasiticides, diagnostics, micro feed ingredients,
supplies, pet food, capital equipment and nutritional products. MWI
also is a leading innovator and provider of value-added services and
technologies used by veterinarians and producers. For more
information about MWI, please visit our website at www.mwivet.com.
For investor relations information please contact Mary Pat Thompson,
Senior Vice President of Finance and Administration, and Chief
Financial Officer at (208) 955-8930 or email
investorrelations@mwivet.com.  
Certain statements contained herein that are not descriptions of
historical facts are "forward-looking" statements (as such term is
defined in the Private Securities Litigation Reform Act of 1995).
Because such statements include risks and uncertainties, actual
results may differ materially from those expressed or implied by such
forward-looking statements. Factors that could cause results to
differ materially from those expressed or implied by such
forward-looking statements include, but are not limited to, those
discussed in filings made by the Company with the Securities and
Exchange Commission. Many of the factors that will determine the
Company's future results are beyond the ability of management to
control or predict. Readers should not place undue r
eliance on
forward-looking statements, which reflect management's views only as
of the date hereof. The Company undertakes no obligation to revise or
update any forward-looking statements, or to make any other
forward-looking statements, whether as a result of new information,
future events or otherwise. Important assumptions and other important
factors that could cause actual results to differ materially from
those set forth in the forward-looking information include the impact
of vendor consolidation on our business; changes in or availability
of vendor contracts or rebate programs; exclusivity requirements with
certain vendors that may prohibit us from distributing competing
products manufactured by other vendors or margin reductions if we
become a non-exclusive distributor; transitional challenges
associated with acquisitions, including the failure to achieve
anticipated synergies; vendor rebates based upon attaining certain
growth goals; changes in the way vendors introduce/deliver products
to market; a disruption caused by adverse weather (i.e. drought) or
other natural conditions or disasters; possible changes in the use of
feed additives (antibiotics, growth promotants) used in the
production animal markets due to trade restrictions, consumer concern
and/or government regulations; seasonality; unforeseen litigation;
risks associated with our international operations; financial risks
associated with acquisitions and investments; the impact of general
economic trends on our business; the recall of a significant product
by one of our vendors; extended shortage or backorder of a
significant product by one of our vendors; the timing and
effectiveness of marketing programs or price changes offered by our
vendors; the timing of the introduction of new products and services
by our vendors; our intellectual property rights may be inadequate to
protect our business; the ability to borrow on our credit line,
extend the terms of our credit line or obtain alternative financing
on favorable terms or at all; risks from potential increases in
variable interest rates; the impact of tightening credit standards
and/or access to credit on behalf of our customers and suppliers;
inability to ship products to the customer as a result of
technological or shipping disruptions; and competition. Other factors
include changes in the rate of inflation; changes in state or federal
legislation or regulation; the continued safety of the products the
Company sells; and changes in the general economy. Investors should
also be aware that while we do, from time to time, communicate with
securities analysts, it is against our policy to disclose any
material non-public information or other confidential commercial
information. Accordingly, stockholders should not assume that we
agree with any statement or report issued by any analyst irrespective
of the content of the statement or report. Furthermore, we have a
policy against issuing or confirming financial forecasts or
projections issued by others. Thus, to the extent that reports issued
by securities analysts contain any projections, forecasts or
opinions, such reports are not the responsibility of MWI Veterinary
Supply, Inc. 
Mary Pat Thompson
Senior Vice President of Finance and Administration and Chief Financial Officer
(208) 955-8930
investorrelations@mwivet.com